Business model innovation opportunities for the biopharmaceutical industry: A systematic review

被引：0
作者：
Downs J.B. [1 ]
Velamuri V.K. [1 ]
机构：
[1] HHL Leipzig Graduate School of Management, Leipzig
来源：
Downs, James B. (james.downs@hhl.de) | 1600年 / ThinkBiotech LLC卷 / 22期
关键词：
Biopharmaceutical; Biotechnology; Business Model; Innovation; Management; Pharmaceutical;
D O I：
10.5912/jcb735
中图分类号：
学科分类号：
摘要：
Research on business model innovation for the biopharmaceutical industry continues to be an area of high global interest due to the combination of industry innovation challenges and global macroeconomic pressures. Through the use of a systematic literature review, this research explores academic literature published from 1976 to 2013 that has addressed business model relevant factors and dynamics in the biopharmaceutical industry. 305 relevant publications were identifed, analyzed, and inductively categorized based on the similarity of their conversations into twelve categories. The authors fnd that opportunities for business model innovation in the biopharmaceutical industry lie in fve key areas: External Orientation, Learning Capabilities, Cluster Participation, Qualifed Business Management Team and Organization Controls. This research provides not only insight into opportunities for business model innovation specifc to this industry but also can be used independently as a valuable reference tool for similar research.
引用
收藏
页码：19 / 63
页数：44
相关论文
共 208 条
[1]  
Marks L.V., Collaboration-A competitor's tool: The story of centocor an entrepreneurial biotechnology company, Bus Hist [Internet], 51, 4, pp. 529-546, (2009)
[2]  
Williams A., Corporate development in biotechnology in 2005, J Commer Biotechnol [Internet], 11, 3, pp. 239-248, (2005)
[3]  
Pisano G.P., Science Business: The Promise the Reality and the Future of Biotech. [Internet], pp. 81-82, (2006)
[4]  
Glick J.L., Biotechnology business models work : Evidence from the pharmaceutical marketplace, J Commer Biotechnol, 14, 2, pp. 106-118, (2008)
[5]  
Powell W., Koput K., Smith-Doerr L., Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology, Adm Sci Q [Internet], 23, 41, pp. 116-145, (1996)
[6]  
Rothaermel F.T., Complementary assets strategic alliances and the incumbent's advantag e: An empirical study of industry and firm effects in the biopharmaceutical industry, Res Policy [Internet], 30, 8, pp. 1235-1251, (2001)
[7]  
Serono and pfizer to co-promote multiple sclerosis treatment rebif(r) in the United States [internet], PR Newswire, (2002)
[8]  
Revenue of the worldwide pharmaceutical market from 2001 to 2014 [internet], In Statista-The Statistics Portal
[9]  
Total biopharmaceutical revenue worldwide from 2006 to 2011 (in billion u.s. Dollars). [internet], In Statista-The Statistics Portal
[10]  
Moore G., Cramming more components onto integrated circuits, Electronics Magazine, 38, 8, pp. 114-117, (1965)
12345678910